Medicine & Healthcare Radiology

A research team led by Osaka University developed a theranostics approach to both diagnose and treat certain pancreatic cancer cases. They radioactively labeled a monoclonal antibody targeting glypican-1, which is highly expressed in pancreatic cancer, then administered it to disease model mice. One label, 89Zr, showed high uptake in tumors, which would allow early detection of pancreatic cancer with PET scans. Another label, 211At, was used with alpha therapy to significantly slow tumor growth.

Researchers from Osaka University found that dietary supplementation with tricaprin results in coronary artery plaque regression and resolution of symptoms in patients with triglyceride deposit cardiomyovasculopathy, a treatment-resistant form of coronary artery disease. These findings represent a conceptually novel treatment for coronary atherosclerosis that paves the way toward establishing a multi-faceted approach to caring for patients with this condition.

Researchers from Osaka University and Dusseldorf University have found a new theranostic compound that effectively shrinks prostate tumor in mice. Theranostics is a cancer treatment that involves finding cancer cells anywhere in the body and delivering targeted radiation to kill those cells, by drugs that contain radioactive isotopes. It means that this compound could be a promising option for treating hormone-resistant metastases in patients with recurrent cancers. This is stated to be tested in an upcoming clinical trial.

Various approaches for treating lymph node metastasis exist. But now, a research team from Tohoku University has combined two forms of therapy to create a superior treatment method than conventional chemotherapy.

Whale and dolphin post-mortem imaging could breathe new life into marine conservation.

Tests show an association between how aggressive a tumour is and the levels of sugar and inflammatory proteins in the blood.